Changeflow GovPing Healthcare & Life Sciences Biopolymers for Ophthalmic Use Patent Application
Routine Notice Added Draft

Biopolymers for Ophthalmic Use Patent Application

Favicon for changeflow.com USPTO Patent Applications - Pharma (A61K)
Published
Detected
Email

Summary

The USPTO has published a patent application (US20260083771A1) for biopolymers intended for ophthalmic use, filed by ExoPolymer, Inc. The application details biopolymers comprising repeating polysaccharide units, their preparations, ophthalmic compositions, and methods of use.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

The United States Patent and Trademark Office (USPTO) has published a new patent application, US20260083771A1, concerning "Biopolymers for Ophthalmic Use." The application, filed by ExoPolymer, Inc., describes novel biopolymers composed of repeating polysaccharide units, along with ophthalmic compositions and methods for their application. This publication represents a new intellectual property filing in the pharmaceutical and medical device sector.

This patent application does not impose immediate compliance obligations on regulated entities. However, it signifies potential future developments in ophthalmic treatments and materials. Companies operating in the pharmaceutical or medical device space, particularly those involved in eye care products, should monitor the progress of this patent application as it may lead to new product development or licensing opportunities. The filing date was September 13, 2023.

Archived snapshot

Mar 27, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

Biopolymers for Ophthalmic Use

Application US20260083771A1 Kind: A1 Mar 26, 2026

Assignee

ExoPolymer, Inc.

Inventors

Derek Wells

Abstract

Provided herein are biopolymers comprising repeating polysaccharide units, preparations of biopolymers, and ophthalmic compositions comprising biopolymers, as well as methods of use.

CPC Classifications

A61K 31/715 A61K 9/0048 A61P 27/04

Filing Date

2023-09-13

Application No.

19109469

View original document →

Get daily alerts for USPTO Patent Applications - Pharma (A61K)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
September 13th, 2023
Instrument
Notice
Legal weight
Non-binding
Stage
Draft
Change scope
Minor
Document ID
US20260083771A1

Who this affects

Applies to
Drug manufacturers Medical device makers
Industry sector
3254 Pharmaceutical Manufacturing 3345 Medical Device Manufacturing
Activity scope
Drug Labeling Medical Device Manufacturing
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Legal
Topics
Medical Devices Intellectual Property

Get alerts for this source

We'll email you when USPTO Patent Applications - Pharma (A61K) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!